MedPath
NMPA Approval

Nitisinone Oral Suspension

国药准字HJ20233126

February 14, 2023

Drug Information

尼替西农口服混悬液

口服混悬剂

90ml:0.36g

化学药品

February 14, 2023

February 13, 2028

Company Information

Applicant Company

SE-112 76,Stockholm, Sweden

Manufacturing Company

Celsiusgatan 43 SE-212 14 Malmö, Sweden

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

尼替西农口服混悬液 - NMPA 批准文号 | MedPath